10.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
Thrivent Financial for Lutherans Sells 8,889 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Teacher Retirement System of Texas Purchases Shares of 10,434 Prothena Co. plc (NASDAQ:PRTA) - Defense World
Benign Growth For Prothena Corporation plc (NASDAQ:PRTA) Underpins Stock's 26% Plummet - simplywall.st
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Amundi Has $28,000 Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
(PRTA) Technical Data - news.stocktradersdaily.com
Bank of New York Mellon Corp Has $2.08 Million Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00 - Defense World
What is Zacks Research’s Forecast for Prothena Q1 Earnings? - The AM Reporter
Zacks Research Has Positive Outlook of Prothena Q1 Earnings - Defense World
Insider Sell: Chief Medical Officer Hideki Garren Sells 2,000 Sh - GuruFocus.com
Zacks Research Weighs in on Prothena FY2027 Earnings - Defense World
Trend Tracker for (PRTA) - Stock Traders Daily
Recent Analysts’ Ratings Changes for Prothena (PRTA) - Defense World
Rhumbline Advisers Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Handelsbanken Fonder AB - Defense World
Prothena Corporation: Multiple Failures Make It Risky (NASDAQ:PRTA) - Seeking Alpha
Prothena (NASDAQ:PRTA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World
PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView
Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus - MSN
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential By Investing.com - Investing.com South Africa
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential - Investing.com India
Prothena (NASDAQ:PRTA) Rating Increased to Hold at StockNews.com - Defense World
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga
Prothena’s (PRTA) “Buy” Rating Reiterated at HC Wainwright - Defense World
Prothena’s (PRTA) “Buy” Rating Reiterated at Chardan Capital - Defense World
Analysts Set Prothena Co. plc (NASDAQ:PRTA) PT at $46.50 - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for Prothena (NASDAQ:PRTA) - Defense World
Royal Bank of Canada Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock Price - Defense World
Prothena Corporation plc (NASDAQ:PRTA) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St
Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript - Insider Monkey
RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk - Marketscreener.com
Prothena Corporation (NASDAQ: PRTA) Gears Up for Transformational 2025 with Key Clinical Milestones - Pradesh Tak
Earnings call transcript: Prothena's Q4 2024 results highlight innovation By Investing.com - Investing.com Australia
Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ... - Yahoo Finance
Earnings call transcript: Prothena's Q4 2024 results highlight innovation - Investing.com
Prothena: Q4 Earnings Snapshot -February 20, 2025 at 04:23 pm EST - Marketscreener.com
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights - Business Wire
(PRTA) Trading Advice - Stock Traders Daily
Prothena Corporation PLC expected to post a loss of $1.04 a shareEarnings Preview - TradingView
Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm - EIN News
The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News
Merck KGaA bids for SpringWorks (SWTX), Evolus (EOLS) receives FDA nod & Prothena (PRTA) struggles - substack.com
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Business Wire
Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight - GlobeNewswire Inc.
Focused Wealth Management Inc Makes New Investment in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Critical Survey: Prothena (NASDAQ:PRTA) vs. Annexon (NASDAQ:ANNX) - Defense World
Prothena (PRTA) to Release Quarterly Earnings on Thursday - Defense World
Prothena (NASDAQ:PRTA) Given New $62.00 Price Target at Oppenheimer - MarketBeat
KALA BIO (NASDAQ:KALA) and Prothena (NASDAQ:PRTA) Financial Survey - Defense World
Prothena (NASDAQ:PRTA) Price Target Raised to $62.00 - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):